BCR-ABL Positive Chronic Myelogenous Leukemia
2 clinical trials · Condition
◉ Watch BCR-ABL Positive Chronic Myelogenous Leukemia
| Record | Firm | Date |
|---|---|---|
| A Study of REduction And DIscontinuation Treatment of TKI (Imatinib, Nilotinib, Dasatinib and Bosutinib) (NCT04578847) | National Research Center for Hematology, Russia | 2020-01-15 |
| Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase (NCT04070443) | Centre Leon Berard | 2019-11-13 |
Track BCR-ABL Positive Chronic Myelogenous Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.